Right Click Capital

Right Click Capital operates from Sydney as an early-stage investor deeply embedded in the Australian technology ecosystem, with an explicit focus on supporting bold founders through pre-seed and seed financings. The firm has built its reputation on providing the kind of governance and ecosystem connections that early-stage Australian companies often struggle to access independently. Healthcare exposure concentrates on AI/ML applications and digital health.

The thesis assumes that the Australian technology ecosystem produces strong technical founders but that the depth of the local pre-seed and seed market is structurally thinner than in larger geographies. Right Click positions itself as a connector and governance partner that bridges this gap, providing not only capital but also the structural support that lets founders compete with their international peers. Healthcare investments under this thesis are typically software-first companies with technology-driven moats and credible regional or international ambition, rather than service-heavy or single-market plays.

The firm writes pre-seed and seed checks generally between $250k and $1M, with the willingness to lead at the earliest stages or participate in syndicates. Geographically, the focus is Australia with selective participation in companies with strong Australian founder ties operating internationally. The check size and stage focus mean Right Click is comfortable being the first institutional money in, often alongside angels or other early-stage funds, and is willing to engage with companies that are still developing their initial commercial traction.

The partnership operates with a small investment team, and the partners are personally engaged in diligence and post-investment support. The firm’s tenure in the Australian ecosystem means the partners have observed multiple cycles and have working relationships with the most active angels, accelerators, and Series A leads in the region. That continuity is structurally valuable for founders navigating the transition from initial financing to subsequent rounds.

In working with companies, Right Click’s most distinctive value is its embeddedness in the Australian ecosystem, which translates into early commercial introductions, governance support, and connections into both regional and international follow-on investors. The firm helps with senior hiring, structuring subsequent rounds, and navigating the specific challenges of building a global company from an Australian base. For healthcare AI founders, the fit is strongest for those building software-first products with international ambition, where the value of an engaged early-stage investor and ecosystem connector outweighs the need for sector-specialist board membership. The fit is weaker for companies that need deep clinical or regulatory specialism, which sits outside the firm’s competency, or for those building primarily for the Australian domestic market without broader ambition. Founders considering Right Click should plan for substantive partner engagement and should welcome an investor active in board and governance matters.